Hydrophobic ion pairing method for encapsulating hydrophilic active ingredients into nanocarriers

Background

The field of pharmaceutical drug delivery relies heavily on nanoparticle formulations to safely transport active pharmaceutical ingredients (APIs) to targeted sites in the body. Nanocarriers are highly sought after to provide controlled release and protect sensitive therapeutic agents from premature degradation. Consequently, there is a critical need to adapt these advanced delivery systems for hydrophilic, water-soluble APIs. Modern medicine increasingly depends on these water-soluble compounds, which include essential biologics such as peptides, proteins, and vital antibiotics. Developing robust delivery mechanisms for these hydrophilic agents is essential to maximize their therapeutic efficacy and improve patient outcomes.

Despite this demand, current encapsulation methods for hydrophilic APIs face significant technical limitations. Traditional nanoprecipitation techniques are highly effective for hydrophobic drugs, but they are fundamentally incompatible with water-soluble agents. To circumvent this, manufacturers typically rely on alternative methods like water-in-oil-in-water emulsions or liposomal formulations. However, these existing approaches are notoriously complex and highly inefficient to scale for industrial production. Furthermore, they consistently suffer from poor performance metrics, specifically resulting in low encapsulation efficiency and inadequate drug loading capacities. This limits the clinical viability of many promising hydrophilic drugs by preventing optimal dosing and controlled delivery profiles.

Technology

This advanced drug delivery solution encapsulates hydrophilic active pharmaceutical ingredients (APIs), such as biologics and antibiotics, into stable nanocarriers. The process utilizes hydrophobic ion-pairing to transiently alter the solubility of water-soluble APIs by binding them with hydrophobic counterions, creating a water-insoluble complex. This complex is processed using Flash NanoPrecipitation, rapidly mixing it with a block copolymer stabilizer and water. The sudden shift in solvent polarity triggers precipitation, prompting the copolymers to self-assemble into stable, PEG-coated nanoparticles. By adjusting the counterion properties and ratios, developers can precisely tune nanoparticle size and drug release rates.

This technology stands out by overcoming the traditional limitations of nanoprecipitation, which was previously restricted to hydrophobic compounds. While conventional encapsulation methods for hydrophilic APIs—like double emulsions or liposomes—are notoriously complex and suffer from low drug loading, this solution achieves exceptional encapsulation efficiencies exceeding 95% and drug loading over 50%. Furthermore, it is a continuous, highly scalable process perfectly suited for industrial manufacturing. Because it relies on ion-pairing rather than creating new covalent bonds, it avoids generating new molecular entities, thereby streamlining regulatory approval pathways while delivering highly customizable therapeutic profiles.

Benefits

• Enables the successful encapsulation of highly water-soluble, hydrophilic active pharmaceutical ingredients (APIs) such as biologics, peptides, and antibiotics, overcoming the limitations of traditional nanoprecipitation.
• Achieves exceptional encapsulation efficiencies (over 95%) and high drug loading capacities (often >50%), significantly outperforming conventional emulsion and liposomal methods.
• Utilizes a continuous Flash NanoPrecipitation (FNP) process that is highly scalable, simple, and easily adaptable for efficient industrial-level production.
• Provides highly tunable controlled release profiles and customizable nanoparticle sizes (25 nm to 1000 nm) by simply adjusting the ion-pairing reagents and formulation ratios.
• Simplifies the regulatory approval process by avoiding covalent modifications to the drug, ensuring no new molecular entities are created.
• Improves overall therapeutic delivery profiles, which can lead to enhanced drug efficacy, targeted mucus penetration, reduced toxicity, and better patient compliance.

Applications

• Hydrophilic pharmaceutical drug reformulation
• Controlled release antibiotic delivery
• Peptide therapeutic nanoparticle formulation
• Protein biologic drug encapsulation
• Scalable nanomedicine manufacturing process

Additional info

This methodology utilizes hydrophobic ion-pairing to transform hydrophilic active pharmaceutical ingredients into water-insoluble complexes. Through Flash NanoPrecipitation in confined impingement jet mixers, these complexes are encapsulated within amphiphilic block copolymers to form stable nanoparticles. This scalable process enables high drug loading and tunable release for peptides and proteins. By modulating counterion hydrophobicity and acid-base strength, nanoparticle size and stability are precisely engineered for therapeutic delivery.